MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 297.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129 | -89.9% | 101,788 | -73.7% | 0.01% | -91.3% |
| Q2 2023 | $1,275 | +51.8% | 387,591 | +89.6% | 0.13% | +53.0% |
| Q1 2023 | $840 | +344.4% | 204,476 | +534.2% | 0.08% | +260.9% |
| Q4 2022 | $189 | -100.0% | 32,241 | -80.7% | 0.02% | -84.7% |
| Q3 2022 | $1,129,000 | +44.7% | 166,992 | -1.0% | 0.15% | +28.2% |
| Q2 2022 | $780,000 | +148.4% | 168,744 | +114.4% | 0.12% | +178.6% |
| Q1 2022 | $314,000 | -42.1% | 78,706 | -9.6% | 0.04% | -38.2% |
| Q4 2021 | $542,000 | +155.7% | 87,065 | +863.2% | 0.07% | -42.4% |
| Q2 2020 | $212,000 | – | 9,039 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |